Aspire Biopharma Holdings, Inc. (ASBP)
9.00
+0.39
(+4.53%)
USD |
NASDAQ |
Sep 10, 14:41
Aspire Biopharma Holdings Total Assets (Quarterly) : 13.54M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.54M |
| March 31, 2026 | 7.117M |
| December 31, 2025 | 1.312M |
| September 30, 2025 | 2.403M |
| June 30, 2025 | 0.9894M |
| March 31, 2025 | 1.966M |
| December 31, 2024 | 0.148M |
| September 30, 2024 | 6.663M |
| June 30, 2024 | 6.868M |
| March 31, 2024 | 20.20M |
| Date | Value |
|---|---|
| December 31, 2023 | 19.98M |
| September 30, 2023 | 19.89M |
| June 30, 2023 | 20.56M |
| March 31, 2023 | 303.11M |
| December 31, 2022 | 300.18M |
| September 30, 2022 | 297.84M |
| June 30, 2022 | 296.72M |
| March 31, 2022 | 296.50M |
| December 31, 2021 | 0.2932M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Resonate Blends, Inc. | 2.825M |
| Breakthrough Chemistry, Inc. | 1.300M |
| Kaya Holdings, Inc. | 0.1994M |
| Cardiac Biotech Solutions, Inc. | 0.5053M |
| Endexx Corp. | 1.509M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.783M |
| Shareholders Equity (Quarterly) | 11.76M |
| Current Ratio | 7.986 |
| Net Debt Paydown Yield | 19.56% |